Image Library

Searchable collection of capillaroscopic images organized by pattern, diagnosis, and severity.

Selected examples

Start exploring

Compare capillary shapes, sizes and hemorrhages.

Browse all images (243) →
Nailfold video capillaroscopy of the right fourth finger showing preserved capillary density with hemorrhages and no giant capillaries
View details

Preserved capillary density with anticoagulation-related hemorrhages

Author: Luis Peñaranda Bolaño

Magnification:
200×
Device:
Inspectis Digital Capillaroscope
Field of view (W × H):
≈ 1.68 × 1.26 mm
Anticoagulation-related hemorrhagesPreserved capillary density with hemorrhagesMild
Nailfold video capillaroscopy in anti-TIF-1gamma antibody-positive dermatomyositis showing enlarged, giant, and ramified capillaries
View details

Dermatomyositis with giant and ramified capillaries

Author: Luis Peñaranda Bolaño

Magnification:
200×
Device:
Inspectis Digital Capillaroscope
Field of view (W × H):
≈ 1.68 × 1.26 mm
DermatomyositisMyositis-associated microangiopathy with neoangiogenesisSevere
A field from the normal reference study, showing the distal row of narrow loops. Use the full study to compare density and shape across fingers.
View details

Normal reference: distal capillary row

Author: Miguel Antonio Mesa Navas

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.35 × 1.32 mm
Normal CapillaroscopyNormal Pattern
Dark hemorrhagic deposits alongside capillary loops in the nonspecific reference study. Hemorrhage alone does not define a scleroderma pattern.
View details

Nonspecific pattern: hemorrhagic field

Author: Miguel Martín Cascón

Magnification:
213.73×
Device:
Dino-Lite Edge
Field of view (W × H):
≈ 1.83 × 1.46 mm
Non-Specific MicroangiopathyNon-Specific Pattern
Selected field from the early-pattern reference study, with enlarged loops among a relatively preserved capillary row. The subtype belongs to the complete examination.
View details

Early scleroderma pattern: selected field

Author: Borja Gracia Tello

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.32 × 1.31 mm
Systemic SclerosisEarly scleroderma pattern
A prominent enlarged loop in the active-pattern reference study. Compare the neighboring capillaries and the other fields before assigning a pattern.
View details

Active scleroderma pattern: giant loop

Author: Borja Gracia Tello

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.43 × 1.37 mm
Systemic SclerosisActive scleroderma pattern
Irregular, ramified loops in a field from the late-pattern reference study. The full study provides context for capillary loss and distribution.
View details

Late scleroderma pattern: disorganized loops

Author: Gema María Lledó Ibáñez

Magnification:
212.3×
Device:
Dino-Lite Edge
Field of view (W × H):
≈ 1.84 × 1.47 mm
Systemic SclerosisLate scleroderma pattern
Large dark hemorrhagic deposits below the capillary row in the published MPO-ANCA vasculitis case. Its complete study is described as a nonspecific pattern without giants.
View details

MPO-ANCA vasculitis: hemorrhagic deposits

Author: Gema María Lledó Ibáñez

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.29 × 1.29 mm
ANCA-Associated Vasculitis (MPO+)Non-Specific Pattern
An overview of the nailfold from the anti-Mi2β dermatomyositis case. This wider view provides context; use the complete study for calibrated measurements and individual capillary assessment.
View details

Anti-Mi2β dermatomyositis: overview

Author: Gema María Lledó Ibáñez

Magnification:
54.28×
Device:
Dino-Lite Edge
Field of view (W × H):
≈ 7.21 × 5.77 mm
Dermatomyositis (anti-Mi2β+)Severe Myositis-Associated Microangiopathy
Overview of the nailfold in the ACA-positive active-pattern case. The reported density and giant-capillary percentage describe the study, not this photograph alone.
View details

ACA-positive systemic sclerosis: overview

Author: Gema María Lledó Ibáñez

Magnification:
50×
Device:
Dino-Lite
Field of view (W × H):
≈ 7.23 × 5.78 mm
Limited Cutaneous Systemic Sclerosis (ACA+)Active scleroderma pattern
Enlarged loops and dark hemorrhagic deposits in the anti-Scl-70-positive active-pattern case. The source report notes no avascular areas in the study.
View details

Anti-Scl-70 systemic sclerosis: enlarged loops and hemorrhages

Author: Gela Gunashvili

Magnification:
211.15×
Device:
Dino-Lite Edge
Field of view (W × H):
≈ 1.67 × 1.34 mm
Diffuse Systemic Sclerosis (anti-Scl-70+)Active scleroderma pattern
Irregular enlarged loops in the anti-U3 RNP case. Although giants remain present, the final report classifies the overall microangiopathy as late.
View details

Anti-U3 RNP systemic sclerosis: irregular loops

Author: Miguel Antonio Mesa Navas

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.39 × 1.34 mm
Systemic Sclerosis (anti-U3 RNP+)Late scleroderma pattern
A disorganized field with enlarged loops and surface reflections from the inter-digit heterogeneity case. Other fields differ markedly; inspect the full study and its image-quality caveats.
View details

Inter-digit heterogeneity: selected abnormal field

Author: Miguel Antonio Mesa Navas

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.32 × 1.31 mm
Systemic Sclerosis (Anticentromere-Positive)Heterogeneous Scleroderma Pattern (Active to Late)
Irregular and branching forms in the anti-RNP-positive mixed connective tissue disease case. The source report describes a scleroderma-like pattern without an assignable Cutolo subtype.
View details

Mixed connective tissue disease: irregular branching forms

Author: Miguel Antonio Mesa Navas

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.30 × 1.29 mm
Mixed Connective Tissue Disease (anti-RNP+)Scleroderma-Like Pattern (Unclassifiable Cutolo Subtype)
Prominent enlarged loops and a complex branching form in the initial anti-NXP2 dermatomyositis study. Compare this with the linked follow-up image and complete serial studies.
View details

Anti-NXP2 dermatomyositis: initial enlarged loops

Author: Luis Saez Comet

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.30 × 1.29 mm
Dermatomyositis (anti-NXP2+)Myositis-Associated Microangiopathy with Treatment Response
Follow-up field from the adult anti-NXP2 dermatomyositis case. The source report documents improved study-wide density and disappearance of giants and hemorrhages; these are longitudinal study findings.
View details

Anti-NXP2 dermatomyositis: follow-up field

Author: Luis Saez Comet

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.27 × 1.28 mm
Dermatomyositis (anti-NXP2+)Follow-up study
Complex, winding and ramified vascular forms in the anti-TIF1γ dermatomyositis case. A scleroderma-like image appearance does not establish systemic sclerosis.
View details

Anti-TIF1γ dermatomyositis: complex vascular shapes

Author: Franklin Uguña Sari

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.39 × 1.34 mm
Dermatomyositis (anti-TIF1γ+)Scleroderma-Like Pattern
Nailfold overview from the juvenile dermatomyositis case with Gottron papules. The complete report describes the vascular abnormalities; this image is an orientation view.
View details

Juvenile dermatomyositis: nailfold overview

Author: Clara Udaondo

Magnification:
50×
Device:
Dino-Lite Edge
Field of view (W × H):
≈ 7.24 × 5.79 mm
Juvenile DermatomyositisLate Scleroderma-Like Pattern
Initial nailfold overview in the juvenile anti-NXP2 longitudinal case. Compare the follow-up and the documented quantitative findings in the complete case.
View details

Juvenile anti-NXP2 dermatomyositis: initial overview

Author: Clara Udaondo

Magnification:
50×
Device:
Dino-Lite
Field of view (W × H):
≈ 7.22 × 5.77 mm
Juvenile Dermatomyositis (anti-NXP2+)Early Scleroderma-Like Pattern with Treatment Response
Follow-up nailfold overview from the same juvenile anti-NXP2 case. Differences in overview appearance should be interpreted alongside acquisition conditions and the serial reports.
View details

Juvenile anti-NXP2 dermatomyositis: follow-up overview

Author: Clara Udaondo

Magnification:
50×
Device:
Dino-Lite
Field of view (W × H):
≈ 7.22 × 5.77 mm
Juvenile Dermatomyositis (anti-NXP2+)Follow-up study
Overview from the active juvenile anti-TIF1 dermatomyositis case. Open the source study to examine the arborizing capillaries described in its report.
View details

Juvenile anti-TIF1 dermatomyositis: nailfold overview

Author: Clara Udaondo

Magnification:
50×
Device:
Dino-Lite
Field of view (W × H):
≈ 7.22 × 5.77 mm
Juvenile Dermatomyositis (anti-TIF1+)Active Scleroderma-Like Pattern
Initial nailfold overview from the longitudinal mixed connective tissue disease case. Use the serial studies to assess change in morphology and density.
View details

Mixed connective tissue disease: initial overview

Author: Clara Udaondo

Magnification:
53.09×
Device:
Dino-Lite Edge
Field of view (W × H):
≈ 7.37 × 5.90 mm
Mixed Connective Tissue Disease (anti-RNP+)Early Scleroderma Pattern with Improvement
Follow-up overview from the same mixed connective tissue disease case. The linked report places this image in the clinical and longitudinal context.
View details

Mixed connective tissue disease: follow-up overview

Author: Clara Udaondo

Magnification:
53.84×
Device:
Dino-Lite Edge
Field of view (W × H):
≈ 7.26 × 5.81 mm
Mixed Connective Tissue Disease (anti-RNP+)Follow-up study
Hairpin capillaries with rounded apices of different widths. The deeper vascular network is visible.
View details

A capillary row above the deeper vascular network

Author: Borja Gracia Tello

Magnification:
250×
Device:
Smart G-Scope
Field of view (W × H):
≈ 2.36 × 1.33 mm
Unequal capillary calibers

Image Usage Guidelines

The atlas is an educational resource. Reuse rights are specific to each image: consult its detail page and the Image licensing and reuse page linked in the footer.

Images explicitly marked CC BY 4.0 may be reused, adapted and published, including commercially, under that licence without additional permission. Other images retain their individual terms.

Consent for educational publication does not by itself establish consent for broader reuse. A copyright licence does not settle patient privacy or other applicable rights.